Maroufi Hossein, Moghadasi Abdorreza Naser, Rezaei-Aliabadi Hossein, Sahraian Mohammad Ali, Eskandarieh Sharareh
Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
Bam University of Medical Sciences, Bam, Iran.
Curr J Neurol. 2021 Apr 4;20(2):86-94. doi: 10.18502/cjn.v20i2.6744.
The association between medical history and primary progressive multiple sclerosis (PPMS) development has not been well documented in the pertinent literature. The possible association between 23 medical diseases and PPMS occurrence was assessed in the present study. In order to figure out the possible association between several medical histories and PPMS occurrence, the present population-based case-control study examined 143 PPMS cases in Tehran, Iran, from 2019 to 2020. Diagnosis of PPMS was confirmed by neurologists based on the 2017 McDonald criteria. Sex-matched healthy controls (n = 143) were selected using the random-digit dialing (RDD) technique. Face-to-face and telephone interviews were conducted for gathering the data. The conditional logistic regression model was used to calculate adjusted and unadjusted odds ratio (OR) at a 95% confidence interval (CI). A significant association was found between PPMS development and diseases like depression (OR = 3.12, 95% CI: 1.49-6.53), migraine (OR = 0.19, 95% CI: 0.05-0.67), infectious mononucleosis (OR = 13.16, 95% CI: 2.74-63.17), hypothyroidism (OR = 3.20, 95% CI: 1.23-8.30), and kidney failure (OR = 3.76, 95% CI: 1.41-9.99). Lifetime history of depression, infectious mononucleosis, hypothyroidism, and kidney failure might increase the risk of PPMS development, while individuals with positive history of migraine disease are at lower risk for developing PPMS.
病史与原发性进行性多发性硬化症(PPMS)发展之间的关联在相关文献中尚未得到充分记载。本研究评估了23种医学疾病与PPMS发生之间的可能关联。为了弄清楚几种病史与PPMS发生之间的可能关联,本基于人群的病例对照研究在2019年至2020年期间对伊朗德黑兰的143例PPMS病例进行了检查。PPMS的诊断由神经科医生根据2017年麦克唐纳标准确认。使用随机数字拨号(RDD)技术选择了性别匹配的健康对照(n = 143)。通过面对面和电话访谈收集数据。使用条件逻辑回归模型计算95%置信区间(CI)下的调整和未调整优势比(OR)。发现PPMS发展与抑郁症(OR = 3.12,95% CI:1.49 - 6.53)、偏头痛(OR = 0.19,95% CI:0.05 - 0.67)、传染性单核细胞增多症(OR = 13.16,95% CI:2.74 - 63.17)、甲状腺功能减退(OR = 3.20,95% CI:1.23 - 8.30)和肾衰竭(OR = 3.76,95% CI:1.41 - 9.99)等疾病之间存在显著关联。抑郁症、传染性单核细胞增多症、甲状腺功能减退和肾衰竭的终身病史可能会增加PPMS发展的风险,而有偏头痛疾病阳性病史的个体患PPMS的风险较低。